Miguel Camafort (Miguel Camafort Babkowski, Miquel Camafort, Miguel Camafort-Babkowski, M Camafort-Babkowski)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Advances in therapy

European heart journal

Clinical hypertension

International journal of heart failure

Universitat de Barcelona

Universitat Rovira i Virgili (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat de Barcelona Oct 01 2015

Spain

Associate Professor :: Medicine

Hospital Clinic. University of Barcelona Nov 29 2011

Spain

Consultant :: General Internal Medicine

Elsevier Doyma Jan 01 2018 - Dec 31 2019

Spain

Editor asociado :: Revista Clínica Española

Hospital Comarcal Mora D'Ebre Jun 18 1998 - May 28 2011

Spain

Especialista :: Medicina Interna

Hospital Universitari Sant Joan de Reus Jan 07 1997 - Jun 17 1998

Spain

Médico Adjunto :: Medicina Interna

Hospital Universitari de Girona Doctor Josep Trueta Jan 06 1992 - Dec 31 1997

Spain

Médico Residente :: Medicina Interna

Institut Catala De La Salut Jan 01 1988 - Dec 31 1991

Spain

Medico general sustituto :: Atención Primaria

Education History

Universitat Rovira i Virgili - Feb 08 2016

Spain

PHD :: Medicina i Cirurgia

Universitat de Barcelona Sep 01 2011 - Jul 01 2012

Spain

MSC :: Medicine

Sociedad Andaluza de Medicina Interna Sep 01 2010 - Jun 27 2011

Spain

MSC :: Medicine

Publications

Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy (2024)
Miriam Mayor, Miguel Camafort, Ramon Estruch
Retinal microvasculature assessment: useful to refine cardiovascular risk. European heart journal (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Miriam Mayor, Miguel Camafort, Ramon Estruch
Retinal microvasculature assessment: useful to refine cardiovascular risk. European heart journal 45 (33) (2024)
Miriam Mayor, Miguel Camafort, Ramon Estruch
Retinal microvasculature assessment: useful to refine cardiovascular risk. European heart journal 45 (33) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Miguel Camafort, Reinhold Kreutz, Myeong-Chan Cho
Diagnosis and management of resistant hypertension. Heart (British Cardiac Society) (2023)
Miguel Camafort, Seong-Mi Park, Seok-Min Kang
Lifestyle Modification in Heart Failure Management: Are We Using Evidence-Based Recommendations in Real World Practice? International journal of heart failure 5 (1) (2023)
Carlos Escobar, Domingo Pascual Figal, Luis Manzano, Julio Nunez, Miguel Camafort
Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin. Journal of clinical medicine 12 (21) (2023)
Miguel Camafort, Seong-Mi Park, Seok-Min Kang
Lifestyle Modification in Heart Failure Management: Are We Using Evidence-Based Recommendations in Real World Practice? International journal of heart failure 5 (1) (2023)
Miguel Camafort, Wook-Jin Chung, Jong Shin Woo
Role of ambulatory blood pressure monitoring in elderly hypertensive patients. Clinical hypertension 28 (1) (2022)
Weimar Kunz Sebba Barroso, Andréa Araujo Brandão, Priscila Valverde de Oliveria Vitorino, Audes Diógenes de Magalhães Feitosa, Eduardo Costa Duarte Barbosa, Roberto Dischinger Miranda, Josep Redón, Miguel Camafort, Antonio Coca, Marco Antônio Mota Gomes
Angiotensin Receptor Blockers Evaluated by Office and Home Blood Pressure Measurements. TeleHBPM Study. Arquivos brasileiros de cardiologia (2022)
José Carlos Arévalo-Lorido, Juana Carretero Gómez, Óscar Aramburu-Bodas, J Grau-Amoros, G Torres-Cortada, Miguel Camafort
Blood Pressure, Congestion and Heart Failure with Preserved Ejection Fraction Among Patients with and Without Type 2 Diabetes Mellitus. A Cluster Analysis Approach from the Observational Registry DICUMAP. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 27 (5) (2020)
Miguel Camafort, Akintunde Adeseye, Antonio Coca, Albertino Damasceno, Giovanni de Simone, Maria Dorobantu, Pardeep S Jhund, Kazuomi Kario, Takahiro Komori, Hae Young Lee, Patricio López-Jaramillo, Okechukwu Samuel Ogah, Sandosh Padmanabahn, Domingo A Pascual-Figal, Wook Bum Pyun, Nicolás Federico Renna, Weimar Kunz Sebba Barroso, Osiris Valdez-Tiburcio, Fernando Stuardo Wyss Quintana
The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry. Rationale, design and objectives. Journal of human hypertension 35 (11) (2020)
Miguel Camafort, Josep Redón, Wook Bum Pyun, Antonio Coca
Intensive blood pressure lowering: a practical review. Clinical hypertension 26 (1) (2020)
Miguel Camafort, Kazuomi Kario
Hypertension, heart failure, and frailty in older people: A common but unclear situation. Journal of clinical hypertension (Greenwich, Conn.) 22 (10) (2020)

Miguel Camafort.css-eqlu8i{font-size:small;padding-left:4px;} (Miguel Camafort Babkowski, Miquel Camafort, Miguel Camafort-Babkowski, M Camafort-Babkowski)

Publication Activity (10 Years)

Top Topics

Top Venues

Miguel Camafort (Miguel Camafort Babkowski, Miquel Camafort, Miguel Camafort-Babkowski, M Camafort-Babkowski)